Residual and Recurrent Gastrointestinal Stromal Tumors With KIT Mutations: Findings at First Follow-Up CT After Imatinib Treatment

被引：3
|
作者：
Choi, Dongil [1 ,2 ]
Yoo, Eun Young [1 ,2 ]
Kim, Kyoung-Mee [3 ]
Sohn, Tae Sung [4 ]
Lee, Won Jae [1 ,2 ]
Lee, Ji Young [1 ,2 ]
Chang, Ilsoo [1 ,2 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Dept Radiol, Kangnam Ku, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Ctr Imaging Sci, Kangnam Ku, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2009年 / 193卷 / 02期
关键词：
cystic change; follow-up CT; gastrointestinal stromal tumor; GIST; imatinib treatment; KIT mutation; POSITRON-EMISSION-TOMOGRAPHY; TYROSINE KINASE; POOR-PROGNOSIS; CYSTIC CHANGES; MESYLATE; INHIBITION; METASTASES; RESISTANCE; DELETIONS; BIOLOGY;
D O I：
10.2214/AJR.08.2106
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The purpose of this study was to correlate findings on the first follow-up CT after treatment with imatinib in patients with residual or recurrent gastrointestinal stromal tumors (GISTs) with the different types of KIT mutation present at initial resection. CONCLUSION. Residual and recurrent GISTs with KIT mutation of exon 11 deletion more frequently showed both tumor shrinkage and cystic change on 2-month follow-up CT images after the start of imatinib treatment than did other mutation types.
引用
收藏
页码：W100 / W105
页数：6
相关论文
共 50 条
  • [21] Appropriate Follow-Up Strategies for Gastrointestinal Stromal Tumor Patients Based on the Analysis of Recurrent Interval and Patterns
    Wada, Noriko
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Nakajima, Kiyokazu
    Masuzawa, Toru
    Nakatsuka, Rie
    Kawada, Junji
    Nishida, Toshirou
    Kimura, Yutaka
    Tanaka, Kouji
    Miyazaki, Yasuhiro
    Makino, Tomoki
    Yamasaki, Makoto
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    DIGESTION, 2017, 95 (02) : 115 - 121
  • [22] Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors A single-center analysis
    Wang, Jian
    Yin, Yuan
    Shen, Chaoyong
    Yin, Xiaonan
    Cai, Zhaolun
    Pu, Lin
    Fu, Wei
    Wang, Yaxuan
    Zhang, Bo
    MEDICINE, 2020, 99 (09)
  • [23] Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib
    Bauer, S
    Hartmann, JT
    de Wit, M
    Lang, H
    Grabellus, F
    Antoch, G
    Niebel, W
    Erhard, J
    Ebeling, P
    Zeth, M
    Taeger, G
    Seeber, S
    Flasshove, M
    Schütte, J
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) : 316 - 325
  • [24] Gastrointestinal stromal tumors: Diagnosis, therapy and follow-up care in Austria
    Bareck, Evelyne
    Ba-Ssalamah, Ahmed
    Brodowicz, Thomas
    Eisterer, Wolfgang
    Haefner, Michael
    Hoegenauer, Christoph
    Kastner, Ulrike
    Kuehr, Thomas
    Laengle, Friedrich
    Liegl-Atzwanger, Bernadette
    Schoppmann, Sebastian F.
    Widmann, Gerlig
    Wrba, Fritz
    Zacherl, Johannes
    Ploner, Ferdinand
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2013, 163 (5-6) : 137 - 152
  • [25] Surgery Combined with Long-Term Imatinib Treatment for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors
    Shou, Chunhui
    Gao, Qing
    Yang, Weili
    Zhang, Qing
    Liu, Xiaosun
    Yu, Jiren
    INDIAN JOURNAL OF SURGERY, 2021, 83 (01) : 38 - 42
  • [26] Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors
    Ogata, Kyoichi
    Kimura, Akiharu
    Nakazawa, Nobuhiro
    Suzuki, Masaki
    Yanoma, Toru
    Ubukata, Yasunari
    Iwamatsu, Kiyohito
    Kogure, Norimichi
    Yanai, Mitsuhiro
    Kuwano, Hiroyuki
    DIGESTION, 2018, 97 (01) : 20 - 25
  • [27] Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from Taiwan
    Yeh, Chun-Nan
    Chen, Yen-Yang
    Tseng, Jeng-Hwei
    Chen, Jen-Shi
    Chen, Tsung-Wen
    Tsai, Chun-Yi
    Cheng, Chi-Tung
    Jan, Yi-Yin
    Chen, Miin-Fu
    TRANSLATIONAL ONCOLOGY, 2011, 4 (06): : 328 - 335
  • [28] Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
    Yin, Yi-qiong
    Liu, Chun-juan
    Zhang, Bo
    Wen, Yue
    Yin, Yuan
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] The Role of Surgical Resection Following Imatinib Treatment in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses
    Park, Seong Joon
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Park, Young Soo
    Sohn, Byeong Seok
    Kim, Hwa Jung
    Kim, Chan Wook
    Kim, Ki-Hun
    Yu, Chang Sik
    Yook, Jeong Hwan
    Kim, Byung Sik
    Kang, Yoon-Koo
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (13) : 4211 - 4217
  • [30] Frequency of KIT Mutation in Gastrointestinal Stromal Tumors According to Histologic and Immunohistochemical Findings, the First Report from Iran
    Geramizadeh, Bita
    Jowkar, Zahra
    Ranjbar, Zeinab
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2015, 40 (04) : 316 - 321
12345